Treatment of primary effusion lymphoma cell lines with lenalidomide

ABSTRACT: Technical replicates from BC3 and BCBL1 cell lines were treated with DMSO or 5 micromoles of lenalidomide for 24 hours. NOTE: Detection p-values were neither computed nor used in this experiment. All data was processed directly from IDATs and the proportion of present probes estimated from the negative and positive controls.

ORGANISM(S): Homo sapiens

PROVIDER: GSE60618 | GEO | 2015/12/28

SECONDARY ACCESSION(S): PRJNA258655

REPOSITORIES: GEO